Literature DB >> 10449852

Laparoscopic extraperitoneal inguinal hernia repair in the day-care setting.

D S O'Riordain1, P Kelly, P G Horgan, F B Keane, W A Tanner.   

Abstract

BACKGROUND: Totally extraperitoneal (TEP) laparoscopic inguinal hernia repair is gaining popularity, and our preference is to perform this procedure as a day case. This study evaluates the suitability of TEP repair in the day-care setting.
METHODS: A policy of day-care TEP repair, unless contraindicated, was adopted for inguinal hernia repair, and the outcome was prospectively evaluated. Of 87 consecutive inguinal hernia repairs, day-care TEP was possible in 54 (62%); 17 (20%) were in-patient TEP, 14 (16%) were open repairs, and 2 (2%) were converted from TEP to open repairs.
RESULTS: Among day-care TEP repairs, median visual analog pain score at discharge was 2.3/10, and 43% of patients had no pain. Complications included cord hematoma 2 (4%) and seroma 3 (6%). Median times for stopping analgesia, resumption of full activity, and return to work were 3, 3, and 6 days respectively. Complete satisfaction with day-care TEP was expressed by 91% of patients; 9% were moderately satisfied, and none expressed dissatisfaction.
CONCLUSIONS: Day-care TEP repair is feasible in the majority of patients with inguinal hernias, and it is associated with minimal complications, excellent recovery, and a high degree of patient satisfaction.

Entities:  

Mesh:

Year:  1999        PMID: 10449852     DOI: 10.1007/s004649901133

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  13 in total

1.  [Surgery of inguinal hernia as ambulatory and brief inpatient surgery].

Authors:  V Schumpelick; M Stumpf; R Schwab
Journal:  Chirurg       Date:  2004-02       Impact factor: 0.955

2.  Cost-effective laparoscopic TEP inguinal hernia repair: the Portsmouth technique.

Authors:  S Basu; S Chandran; S S Somers; S K C Toh
Journal:  Hernia       Date:  2005-11-05       Impact factor: 4.739

3.  [(section sign) 115 b SGB V threatens outpatient treatment for inguinal hernia. Analysis of outcome and economics].

Authors:  D Weyhe; C Winnemöller; A Hellwig; K Meurer; H Plugge; K Kasoly; H Laubenthal; K-H Bauer; W Uhl
Journal:  Chirurg       Date:  2006-09       Impact factor: 0.955

4.  Pre-peritoneal local anaesthetic does not reduce post-operative pain in laparoscopic total extra-peritoneal inguinal hernia repair: double-blinded randomized controlled trial.

Authors:  S Kulasegaran; M Rohan; L Pearless; M Hulme-Moir
Journal:  Hernia       Date:  2017-10-16       Impact factor: 4.739

5.  Laparoscopic transabdominal preperitoneal (TAPP) hernia repair. A 7-year two-center experience in 3017patients.

Authors:  S A Kapiris; W A Brough; C M Royston; C O'Boyle; P C Sedman
Journal:  Surg Endosc       Date:  2001-07-05       Impact factor: 4.584

6.  Pre-emptive infiltration of Bupivacaine in laparoscopic total extraperitoneal hernioplasty: a randomized controlled trial.

Authors:  S F Hon; C M Poon; H T Leong; Y C Tang
Journal:  Hernia       Date:  2008-08-13       Impact factor: 4.739

7.  Minimally invasive techniques in common surgical procedures: implications for training.

Authors:  P H McCormick; W A Tanner; F B V Keane; S Tierney
Journal:  Ir J Med Sci       Date:  2003 Jan-Mar       Impact factor: 1.568

8.  Preperitoneal bupivacaine attenuates pain following laparoscopic inguinal hernia repair.

Authors:  A Bar-Dayan; M Natour; B Bar-Zakai; O Zmora; M Shabtai; A Ayalon; J Kuriansky
Journal:  Surg Endosc       Date:  2004-05-27       Impact factor: 4.584

9.  [Laparoscopy: potential and limitations in outpatient and short-term inpatient surgery].

Authors:  H Feussner
Journal:  Chirurg       Date:  2004-03       Impact factor: 0.955

Review 10.  Effect of extraperitoneal bupivacaine analgesia in laparoscopic inguinal hernia repair: a meta-analysis of randomized controlled trials.

Authors:  Y-S Tong; C-C Wu; C-H Bai; H-C Lee; H-H Liang; L-J Kuo; P-L Wei; K-W Tam
Journal:  Hernia       Date:  2013-05-05       Impact factor: 4.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.